123 related articles for article (PubMed ID: 24507001)
21. The Glasgow Prognostic Score (GPS) as a novel and significant predictor of extranodal natural killer/T-cell lymphoma, nasal type.
Li YJ; Jiang WQ; Huang JJ; Xia ZJ; Huang HQ; Li ZM
Am J Hematol; 2013 May; 88(5):394-9. PubMed ID: 23423859
[TBL] [Abstract][Full Text] [Related]
22. Nasopharyngeal/nasal type NK/T lymphoma: analysis of 23 cases and current review of the literature.
Youssef YB; Bougmiza I; Bouabid Z; Achour B; Regaieg H; Sriha B; Belkadhi M; Omri HE; Khelif A
Kulak Burun Bogaz Ihtis Derg; 2012; 22(5):275-83. PubMed ID: 22991988
[TBL] [Abstract][Full Text] [Related]
23. Clinical features and survival of extranodal natural killer/T cell lymphoma with and without hemophagocytic syndrome.
Jia J; Song Y; Lin N; Liu W; Ping L; Zheng W; Wang X; Xie Y; Tu M; Zhang C; Ying Z; Deng L; Ding N; Zhu J
Ann Hematol; 2016 Dec; 95(12):2023-2031. PubMed ID: 27595760
[TBL] [Abstract][Full Text] [Related]
24. Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study.
Lee J; Suh C; Park YH; Ko YH; Bang SM; Lee JH; Lee DH; Huh J; Oh SY; Kwon HC; Kim HJ; Lee SI; Kim JH; Park J; Oh SJ; Kim K; Jung C; Park K; Kim WS
J Clin Oncol; 2006 Feb; 24(4):612-8. PubMed ID: 16380410
[TBL] [Abstract][Full Text] [Related]
25. CD30 expression is a novel prognostic indicator in extranodal natural killer/T-cell lymphoma, nasal type.
Li P; Jiang L; Zhang X; Liu J; Wang H
BMC Cancer; 2014 Nov; 14():890. PubMed ID: 25429803
[TBL] [Abstract][Full Text] [Related]
26. [Clinical analysis of 202 cases of extranodal NK/T-cell lymphoma].
Ma C; Bo J; Liu T; Yao S; Zhao Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):999-1004. PubMed ID: 25130817
[TBL] [Abstract][Full Text] [Related]
27. Extranodal NK/T-cell lymphoma with cutaneous involvement: 'nasal' vs. 'nasal-type' subgroups--a retrospective study of 18 patients.
Choi YL; Park JH; Namkung JH; Lee JH; Yang JM; Lee ES; Lee DY; Jang KT; Ko YH
Br J Dermatol; 2009 Feb; 160(2):333-7. PubMed ID: 19014396
[TBL] [Abstract][Full Text] [Related]
28. Nasal endoscopic evaluation and its impact on survival in patients with stage I/II extranodal natural killer/T-cell lymphoma, nasal type.
Cho HJ; Jang MS; Hong SD; Kim SJ; Ahn YC; Oh D; Ko YH; Kim HY; Dhong HJ; Chung SK; Kim WS
Int Forum Allergy Rhinol; 2015 Oct; 5(10):960-6. PubMed ID: 26039707
[TBL] [Abstract][Full Text] [Related]
29. [Prognostic analysis of patients with nasal-type NK/T-cell non-Hodgkin's lymphoma--a report of 93 cases].
Pan ZH; Huang HQ; Lin XB; Xia YF; Xia ZJ; Peng YL; Cai QQ; Lin TY; Jiang WQ; Guan ZZ
Ai Zheng; 2005 Dec; 24(12):1493-7. PubMed ID: 16351799
[TBL] [Abstract][Full Text] [Related]
30. Extranodal nasal type NK/T-cell lymphoma: elucidating clinical prognostic factors for risk-based stratification of therapy.
Lee J; Park YH; Kim WS; Lee SS; Ryoo BY; Yang SH; Park KW; Kang JH; Park JO; Lee SH; Kim K; Jung CW; Park YS; Im YH; Kang WK; Lee MH; Ko YH; Ahn YC; Park K
Eur J Cancer; 2005 Jul; 41(10):1402-8. PubMed ID: 15963893
[TBL] [Abstract][Full Text] [Related]
31. [Clinical study of 34 patients with extranodal NK/T cell lymphoma-nasal type].
Ren X; Jia Q; Xiang G; Zhao Z; Xu K; Du W
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Apr; 21(8):361-2. PubMed ID: 17608157
[TBL] [Abstract][Full Text] [Related]
32. [Study of prognostic related factors of elderly patients with T/NK cell lymphoma].
Wang Y; Qian Y; Wu LL; Zhao BB; Xu PP; Zhao WL; Wang L
Zhonghua Xue Ye Xue Za Zhi; 2013 Jan; 34(1):12-5. PubMed ID: 23597457
[TBL] [Abstract][Full Text] [Related]
33. Clinical significance of cyclooxygenase-2 expression in extranodal natural killer (NK)/T-cell lymphoma, nasal type.
Shim SJ; Yang WI; Shin E; Koom WS; Kim YB; Cho JH; Suh CO; Kim JH; Kim GE
Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):31-8. PubMed ID: 17049184
[TBL] [Abstract][Full Text] [Related]
34. [Clinical features and prognosis of nasal type NK/T cell lymphoma].
Zhang YJ; Hu WH; Liu H; Cheng EC; Ren ZM; Xia YF; Cui NJ
Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):50-3. PubMed ID: 16737622
[TBL] [Abstract][Full Text] [Related]
35. Prognostic factors for classifying extranodal NK/T cell lymphoma, nasal type, as lymphoid neoplasia.
Na II; Kang HJ; Park YH; Lee SS; Yoo HJ; Choe DH; Ryoo BY; Yang SH
Eur J Haematol; 2007 Jul; 79(1):1-7. PubMed ID: 17598834
[TBL] [Abstract][Full Text] [Related]
36. Extranodal natural killer/T-Cell lymphoma: A population-based comparison of sinonasal and extranasal disease.
Vazquez A; Khan MN; Blake DM; Sanghvi S; Baredes S; Eloy JA
Laryngoscope; 2014 Apr; 124(4):888-95. PubMed ID: 24114591
[TBL] [Abstract][Full Text] [Related]
37. A prognostic model based on pretreatment platelet lymphocyte ratio for stage IE/IIE upper aerodigestive tract extranodal NK/T cell lymphoma, nasal type.
Wang KF; Chang BY; Chen XQ; Liu PP; Wuxiao ZJ; Wang ZH; Li S; Jiang WQ; Xia ZJ
Med Oncol; 2014 Dec; 31(12):318. PubMed ID: 25377661
[TBL] [Abstract][Full Text] [Related]
38. [Clinical characteristics and treatment of midline nasal and nasal type NK/T cell lymphoma].
Yong W; Zheng W; Zhang Y
Zhonghua Yi Xue Za Zhi; 2001 Jul; 81(13):773-5. PubMed ID: 11798962
[TBL] [Abstract][Full Text] [Related]
39. Natural Killer/T Cell Lymphoma, Nasal Type: A Retrospective Clinical Analysis in North-Western China.
Liang R; Wang Z; Bai QX; Gao GX; Yang L; Zhang T; Gu HT; Dong BX; Shu MM; Hao CX; Zhang N; Chen XQ
Oncol Res Treat; 2016; 39(1-2):45-52. PubMed ID: 26891121
[TBL] [Abstract][Full Text] [Related]
40. Development of new prognostic model based on pretreatment βLRI and LLRI for stage IE/IIE upper aerodigestive tract ENKTL, nasal type.
Dai W; Jia B; Yang J; Zhou S; Liu P; He X; Qin Y; Gui L; Zhang C; Han X; Sun Y; Shi Y
Oncotarget; 2017 May; 8(21):34787-34795. PubMed ID: 28410236
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
